Study of AERAS 422 in Healthy Adults

A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy

NCT00002085 ·Status: COMPLETED ·Phase: NA

Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland

NCT04648800 ·Status: UNKNOWN ·Phase: PHASE3

TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis

NCT00523926 ·Status: COMPLETED ·Phase: PHASE2

Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19

NCT04350931 ·Status: UNKNOWN ·Phase: PHASE3

Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults

NCT04537663 ·Status: COMPLETED ·Phase: PHASE4

TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).

NCT00449644 ·Status: COMPLETED ·Phase: PHASE2

Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination

NCT04417335 ·Status: UNKNOWN ·Phase: PHASE4

Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.

NCT04362124 ·Status: WITHDRAWN ·Phase: PHASE3

Effects of BCG on Immune Response

NCT02085590 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis

NCT03181932 ·Status: COMPLETED ·Phase: PHASE3

Azithromycin a Treatment for Pulmonary Sarcoidosis

NCT04020380 ·Status: COMPLETED ·Phase: PHASE2

Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers

NCT04461379 ·Status: UNKNOWN ·Phase: PHASE3

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

NCT07213765 ·Status: RECRUITING ·Phase: PHASE4

Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.

NCT00205816 ·Status: COMPLETED ·Phase: PHASE3

A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus.

NCT06719219 ·Status: COMPLETED ·Phase: PHASE1

A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

NCT01250249 ·Status: COMPLETED ·Phase: PHASE3

Trial of Antimycobacterial Therapy in Sarcoidosis

NCT01074554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

NCT00079976 ·Status: COMPLETED ·Phase: PHASE3

Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana

NCT02281643 ·Status: COMPLETED ·Phase: PHASE2

Antibiotics and Vaccine Immune Responses Study

NCT06148025 ·Status: RECRUITING ·Phase: PHASE4

Initial and Chronic Methicillin Resistant Staphylococcus Aureus (MRSA) Infection in Cystic Fibrosis (CF)

NCT02684422 ·Status: COMPLETED

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BLMZ Chinese Cohort

NCT07268664 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

NCT00990145 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers

NCT07029932 ·Status: RECRUITING ·Phase: PHASE1

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

NCT05716425 ·Status: COMPLETED ·Phase: PHASE3